A study has found that mutations in the TP53 gene affect the response to lung cancer treatment. The relationship between TP53 mutations and lung cancer treatment outcomes is being explored in various research studies, with some focusing on the potential for targeted therapies and immunotherapy. The impact of TP53 mutations on lung cancer treatment is an area of ongoing research, with multiple studies examining its role in different types of lung cancer.